Fig. 4

The relationship of overall survival with the aberrant methylation of the SEPTIN9, SDC2, and BCAT1 gene based on 6-month and 12-month survival time as the endpoint criteria of CRC patients. * pā<ā0.05, ** pā<ā0.01, *** pā<ā0.001.
The relationship of overall survival with the aberrant methylation of the SEPTIN9, SDC2, and BCAT1 gene based on 6-month and 12-month survival time as the endpoint criteria of CRC patients. * pā<ā0.05, ** pā<ā0.01, *** pā<ā0.001.